VR AI Meditation for Pain
- Conditions
- Pain and Anxiety
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Christopher Almario
- Target Recruit Count
- 38
- Registration Number
- NCT07122843
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
- Conditions
- Cancer RiskBreast Cancer Risk
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 400
- Registration Number
- NCT07121972
- Locations
- 🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
🇺🇸University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
Symptoms and Coping Strategies Among Patients With Implantable Cardioverter Defibrillator
- Conditions
- Heart FailureSudden Cardiac ArrestVentricular Arrhythmias
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- TC Erciyes University
- Target Recruit Count
- 142
- Registration Number
- NCT07121855
- Locations
- 🇹🇷
Turkish Ministry of Health, Adana City Training and Research Hospital, Sinop, Turkey
Prizvalve Transcatheter Aortic Valve in Failing Bioprosthetic Valves
- Conditions
- Failing Bioprosthetic Valves
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Xijing Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT07122050
- Locations
- 🇨🇳
Department of Cardiovascular Surgery of Xijing Hospital, Air Force Military Medical University, Xi'an, Shaanxi, China
Sex Differences in NMDA-enhancing Treatment of Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- Drug: NMDAEDrug: Placebo Cap
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- China Medical University Hospital
- Target Recruit Count
- 90
- Registration Number
- NCT07122895
- Locations
- 🇨🇳
Department of Psychiatry, China Medical University Hospital, Taichung, Taiwan
Usability of the MeTime MS App
- Conditions
- Multiple SclerosisPainFatigue Symptom
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Michigan
- Target Recruit Count
- 10
- Registration Number
- NCT07123272
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
A Phase 2 Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
- Conditions
- Metastatic Renal Cell CarcinomaMetastatic Renal CancerRenal Cell CarcinomaAdvanced Clear Cell Renal Cell CarcinomaKidney CancerTranslocation Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Stephanie Berg
- Target Recruit Count
- 25
- Registration Number
- NCT07123090
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
- Conditions
- Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Target Recruit Count
- 170
- Registration Number
- NCT07122687
- Locations
- 🇨🇳
Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men
- Conditions
- Anal HSILAnal AIN3Anal HPV Infection
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Bispebjerg Hospital
- Target Recruit Count
- 700
- Registration Number
- NCT07123558
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Conditions
- Rheumatoid Arthritis (RA)Hidradenitis Suppurativa (HS)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Sonoma Biotherapeutics, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT07123038
- Locations
- 🇺🇸
UCSF Medical Center, San Francisco, California, United States
🇺🇸Stanford Medical Center, Stanford, California, United States
🇺🇸University of Colorado, Aurora, Colorado, United States